visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Alexo Therapeutics

    Get Full Access

    Description

    • Alexo Therapeutics is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism exploited by cancer cells to evade the immune system. Our lead candidate, ALX148, is a fusion protein that comprises an engineered high affinity CD47 binding domain of SIRPa linked to an inactive Fc region of human immunoglobulin. ALX148 is designed to enhance the efficacy of antibody-based therapies and is in clinical development for a broad range of tumor types. For more information about the company, please visit our website at www.alexotherapeutics.com
    • location

      Headquarters:866 Malcolm Road Suite 100, Burlingame, California, United States

      More
    • Alexo Therapeutics phone

      Phone Number:

    • Alexo Therapeutics website

      Website: https://www.alexotherapeutics.com

    • Alexo Therapeutics employees

      Employees:25

    • Alexo Therapeutics revenue

      Revenue:$10 - 50M

    • Alexo Therapeutics legal name

      Legal Name:Alexo Therapeutics

    • Alexo Therapeutics's Social Media

      Alexo Therapeutics linkedin Alexo Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Alexo Therapeutics

    Jaume Pons

    President And Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Yasmina Abdiche

    Chief Scientific Officer

    Pete Garcia

    Chief Financial Officer

    Sophia Randolph

    Chief Medical Officer

    Jeanne Jew

    Chief Business Officer

    Hank Stern

    Vice President, Cmc, Inc

    Frequently Asked Questions regarding Alexo Therapeutics

    • Where are Alexo Therapeutics's Headquarters?

      Alexo Therapeutics's Headquarters are in 866 Malcolm Road Suite 100,Burlingame,California,United States

    • What is Alexo Therapeutics's official website?

      Alexo Therapeutics's official website is https://www.alexotherapeutics.com

    • What is Alexo Therapeutics's Revenue?

      Alexo Therapeutics's revenue is $10 - 50M

    • What is Alexo Therapeutics's NAICS code?

      Alexo Therapeutics's NAICS code is 541713

    • How many employees are working in Alexo Therapeutics

      Alexo Therapeutics has 25 employees

    • What is Alexo Therapeutics's Industry?

      Alexo Therapeutics is in the industry of Biotechnology

    • Who is Alexo Therapeutics's CEO?

      Alexo Therapeutics's CEO is Jaume Pons

    • Who is Alexo Therapeutics's Chief Scientific Officer?

      Alexo Therapeutics's Chief Scientific Officer is Yasmina Abdiche

    Company Directory